Susan Quaggin
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2023-10-11
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-10 · its source page states the value and the date
- Confidence
- 0.95
Sources
“On October 11, 2023, AbbVie Inc. (“AbbVie”) expanded the size of its Board of Directors (the “Board”) from eleven directors to thirteen directors and appointed Jennifer Davis as a Class II director and Susan Quaggin as a Class III director.”— what the page says, read 2026-11-10
- https://www.wikidata.org/wiki/Q14662364
- https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm
Cite this claim
Plain text
AsOf. "AbbVie board member: Susan Quaggin", as of 2023-10-11. Claim clm_7402240BD8F8, https://asof.is/claim/clm_7402240BD8F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm.
APA
AsOf. (2023). AbbVie board member: Susan Quaggin (as of 2023-10-11) [Record clm_7402240BD8F8]. Retrieved November 10, 2026, from https://asof.is/claim/clm_7402240BD8F8 (source: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm)
BibTeX
@misc{asof_clm_7402240BD8F8,
author = {AsOf},
title = {AbbVie board member: Susan Quaggin},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_7402240BD8F8}},
note = {Claim clm\_7402240BD8F8, as of 2023-10-11; source: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1\_8k.htm},
urldate = {2026-11-10}
}On the record
/claim/clm_7402240BD8F8.md/v1/claims/clm_7402240BD8F8submit a correction